196 related articles for article (PubMed ID: 11027624)
1. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
[TBL] [Abstract][Full Text] [Related]
2. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
3. HT-1080 fibrosarcoma cell matrix degradation and invasion are inhibited by the matrix-associated serine protease inhibitor TFPI-2/33 kDa MSPI.
Rao CN; Cook B; Liu Y; Chilukuri K; Stack MS; Foster DC; Kisiel W; Woodley DT
Int J Cancer; 1998 May; 76(5):749-56. PubMed ID: 9610735
[TBL] [Abstract][Full Text] [Related]
4. Extracellular matrix-associated serine protease inhibitors (Mr 33,000, 31,000, and 27,000) are single-gene products with differential glycosylation: cDNA cloning of the 33-kDa inhibitor reveals its identity to tissue factor pathway inhibitor-2.
Rao CN; Reddy P; Liu Y; O'Toole E; Reeder D; Foster DC; Kisiel W; Woodley DT
Arch Biochem Biophys; 1996 Nov; 335(1):82-92. PubMed ID: 8914837
[TBL] [Abstract][Full Text] [Related]
5. Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.
Rao CN; Mohanam S; Puppala A; Rao JS
Biochem Biophys Res Commun; 1999 Feb; 255(1):94-8. PubMed ID: 10082661
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
[TBL] [Abstract][Full Text] [Related]
7. Refold and characterization of recombinant tissue factor pathway inhibitor expressed in Escherichia coli.
Diaz-Collier JA; Palmier MO; Kretzmer KK; Bishop BF; Combs RG; Obukowicz MG; Frazier RB; Bild GS; Joy WD; Hill SR
Thromb Haemost; 1994 Mar; 71(3):339-46. PubMed ID: 8029799
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.
Konduri SD; Tasiou A; Chandrasekar N; Rao JS
Int J Oncol; 2001 Jan; 18(1):127-31. PubMed ID: 11115549
[TBL] [Abstract][Full Text] [Related]
9. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
[TBL] [Abstract][Full Text] [Related]
10. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and biology of tissue factor pathway inhibitor-2.
Chand HS; Foster DC; Kisiel W
Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383
[TBL] [Abstract][Full Text] [Related]
12. The role of tissue factor pathway inhibitor-2 in cancer biology.
Sierko E; Wojtukiewicz MZ; Kisiel W
Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
[TBL] [Abstract][Full Text] [Related]
13. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
[TBL] [Abstract][Full Text] [Related]
14. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of recombinant human alpha1-proteinase inhibitor and its single amino acid substituted variants in Escherichia coli for enhanced stability and biological activity.
Agarwal S; Jha S; Sanyal I; Amla DV
J Biotechnol; 2010 May; 147(1):64-72. PubMed ID: 20346993
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells.
Neaud V; Hisaka T; Monvoisin A; Bedin C; Balabaud C; Foster DC; Desmoulière A; Kisiel W; Rosenbaum J
J Biol Chem; 2000 Nov; 275(45):35565-9. PubMed ID: 10954721
[TBL] [Abstract][Full Text] [Related]
17. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies.
Richter W; Hermsdorf T; Kronbach T; Dettmer D
Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709
[TBL] [Abstract][Full Text] [Related]
18. Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line.
Kempaiah P; Kisiel W
Apoptosis; 2008 May; 13(5):702-15. PubMed ID: 18401718
[TBL] [Abstract][Full Text] [Related]
19. Characterization and biological activities of recombinant human plasminogen kringle 1-3 produced in Escherichia coli.
You WK; So SH; Sohn YD; Lee H; Park DH; Chung SI; Chung KH
Protein Expr Purif; 2004 Jul; 36(1):1-10. PubMed ID: 15177278
[TBL] [Abstract][Full Text] [Related]
20. Subcellular localization of PP5/TFPI-2 in human placenta: a possible role of PP5/TFPI-2 as an anti-coagulant on the surface of syncytiotrophoblasts.
Udagawa K; Yasumitsu H; Esaki M; Sawada H; Nagashima Y; Aoki I; Jin M; Miyagi E; Nakazawa T; Hirahara F; Miyazaki K; Miyagi Y
Placenta; 2002; 23(2-3):145-53. PubMed ID: 11945080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
